This is to inform you that, for the purpose of declaration of Unaudited Financial Results of the Company, the trading window shall remain closed from Tuesday, June 30, 2026 (close of business) till 48 hours after financial results are made public.

pdf

Pfizer Ltd.

06 Jun 2026

4731.40

3.08%

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Business Line

The drugmaker aims for berobenatide to be the first monthly GLP-1 weight-loss injection, distinguishing it from blockbuster drugs like Wegovy and Eli Lilly's Zepbound

Pfizer Ltd. has an average target of 5925.00 from 2 brokers.

Pfizer Ltd.

04 Jun 2026

4731.40

3.08%

Company Update

Pfizer Ltd - 500680 - Newspaper Advertisement

BSE India

Please find enclosed Newspaper Advertisement for transfer of unclaimed Dividend and Shares to IEPF.

pdf

Pfizer Ltd.

03 Jun 2026

4731.40

3.08%

Company Update

Pfizer Ltd - 500680 - Newspaper Advertisement

BSE India

Special Window for Re-lodgement of Transfer and Dematerialisation of Physical Securities.

pdf

Pfizer Ltd.

29 May 2026

4731.40

3.08%

Pfizer inks up to $10.5 billion deal with China's Innovent Biologics

Business Line

The collaboration spans a portfolio of 12 oncology programs, comprising eight Innovent-originated early-stage assets and four Pfizer-proposed discovery programmes

Pfizer Ltd.'s price crossed above 50Day SMA today

Is Pfizer Ltd. worth buying?

216 Votes:

Buy 74.54%

Sell 14.35%

Hold 11.11%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf